Potassium Chloride In Lactated Ringers And Dextrose Injection, Solution
NDC Package 0338-0811-04
Package Information
Potassium Chloride In Lactated Ringers And Dextrose (dextrose monohydrate, sodium chloride, sodium lactate, potassium chloride, calcium chloride) injection is potassium Chloride in Lactated Ringer’s and 5% Dextrose Injection, USP are indicated as a source of water, electrolytes, and calories or as alkalinizing agents. This formulation utilizes a injection, solution delivery system. Marketed by Baxter Healthcare Corporation, this product is identified by NDC 0338-0811 and is authorized under FDA application NDA019367.
Identification & Billing
- RxCUI: 847626 - potassium chloride 20 MEQ/L in lactated Ringers solution with dextrose 5 % Injectable Solution
- RxCUI: 847626 - calcium chloride 0.2 MG/ML / glucose 50 MG/ML / potassium chloride 1.79 MG/ML / sodium chloride 6 MG/ML / sodium lactate 3.1 MG/ML Injectable Solution
- RxCUI: 847626 - calcium chloride 0.2 MG/ML / glucose 50 MG/ML / K+ chloride 1.79 MG/ML / NaCl 6 MG/ML / sodium lactate 3.1 MG/ML Injectable Solution
- RxCUI: 847626 - calcium chloride 0.2 MG/ML / glucose 50 MG/ML / Pot chloride 1.79 MG/ML / NaCl 6 MG/ML / sodium lactate 3.1 MG/ML Injectable Solution
- RxCUI: 847626 - calcium chloride 20 MG / potassium chloride 179 MG / sodium chloride 600 MG / sodium lactate 310 MG per 100 ML Ringer's with dextrose 5 % Injectable Solution
Clinical Specifications
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Cations, Divalent - [CS]
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 0338 - Baxter Healthcare Corporation
- 0338-0811 - Potassium Chloride In Lactated Ringers And Dextrose
- 0338-0811-04 - 1000 mL in 1 BAG
- 0338-0811 - Potassium Chloride In Lactated Ringers And Dextrose
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0338-0811-04 identifies a specific commercial package of 1000 ml in 1 bag of Potassium Chloride In Lactated Ringers And Dextrose, a human prescription drug labeled by Baxter Healthcare Corporation. This product is billed per "ML" milliliter and contains an estimated amount of 1000 billable units per package. This injection, solution is formulated for intravenous use and contains calcium chloride; dextrose monohydrate; potassium chloride; sodium chloride; sodium lactate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Baxter Healthcare Corporation on April 05, 1985. The current certification is valid through December 31, 2026.
How is this Baxter Healthcare Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00338081104. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 1000 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.